trending Market Intelligence /marketintelligence/en/news-insights/trending/L4fnTTzNgF3tPlay08AN-A2 content esgSubNav
In This List

Cerulean Pharma transfers listing to Nasdaq Capital Market

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Cerulean Pharma transfers listing to Nasdaq Capital Market

Cerulean Pharma Inc. transferred the listing of its stock to the Nasdaq Capital Market from the Nasdaq Global Market.

The company's stock will continue to trade under the symbol CERU.

Cerulean Pharma received two notices of noncompliance from the stock exchange before applying to transfer the listing of its stock.